Deborah C. Silverstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Deborah C. Silverstein has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Kenneth J. Drobatz
6 shared publications- Nolan Vincent Chalifoux
University of Pennsylvania, School of Veterinary Medicine Department of Clinical Sciences & Advanced Medicine Philadelphia, Pennsylvania
3 shared publications Rebecka S. Hess
Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA
3 shared publicationsDarko Stefanovski
Department of Clinical Studies New Bolton Center University of Pennsylvania, School of Veterinary Medicine Philadelphia Pennsylvania USA
2 shared publicationsDebra T. Liu
Matthew J. Ryan Veterinary Teaching Hospital, University of Pennsylvania, 3900 Delancey St, Philadelphia, PA, 19104
2 shared publicationsFrances S. Shofer
Department of Emergency Medicine, University of North Carolina, Chapel Hill, NC 27599
2 shared publications
Latest Publications
- 1 May 2026
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 264 (5) , 1-7
Mechanical ventilation beyond 24 hours is associated with improved survival outcomes in dogs: a multi-institutional analysis of 258 cases (2019–2025)
Objective: To evaluate survival outcomes in dogs undergoing mechanical ventilation (MV) when accounting for ventilation duration and euthanasia context, and to determine survival rates in patients ventilated ≥ 24 hours. Methods: In this retrospective observational study, records were reviewed from dogs undergoing all-cause MV at 3 academic referral hospitals and 2 private specialty hospitals between March 2019 and January 2025. Data collected included underlying diagnosis, indication for MV, ventilation duration, and outcome. Indications were categorized as increased work of breathing, severe hypoxemia (Pao 2 < 60 mm Hg or peripheral oxygen saturation of hemoglobin as measured by pulse oximetry < 90% despite supplemental oxygen), or hypoventilation (Pa co 2 ≥ 60 mm Hg). Ventilation duration was classified as < 24 hours or ≥ 24 hours, and reasons for euthanasia were recorded when available. Results: Of 258 dogs, 85 (32.9%) survived to discharge, 105 (40.7%) were euthanized, and 68 (26.4%) died. Survival was 52.3% for dogs ventilated ≥ 24 hours compared to 13.3% for those ventilated < 24 hours. Overall, 64.7% of euthanasias occurred within 24 hours and 28.6% were financially driven. Median ventilation duration among survivors was 48 hours (range, 24 to 356 hours). Conclusions: This multi-institutional study demonstrates improved survival outcome with a 52% survival to discharge for patients ventilated ≥ 24 hours compared to patients ventilated < 24 hours. These findings suggest that once a patient surpasses the initial 24-hour period on MV, prognosis stabilizes at approximately 50:50, aligning more closely with human ICU survival rates. Clinical Relevance: These findings support MV as a viable therapeutic option in veterinary critical care, and updated survival statistics provide a basis for prognostic discussions and treatment decisions.
- 1 May 2026
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 264 (5) , 1-7
Mechanical ventilation beyond 24 hours is associated with improved survival outcomes in dogs: a multi-institutional analysis of 258 cases (2019–2025)
Objective: To evaluate survival outcomes in dogs undergoing mechanical ventilation (MV) when accounting for ventilation duration and euthanasia context, and to determine survival rates in patients ventilated ≥ 24 hours. Methods: In this retrospective observational study, records were reviewed from dogs undergoing all-cause MV at 3 academic referral hospitals and 2 private specialty hospitals between March 2019 and January 2025. Data collected included underlying diagnosis, indication for MV, ventilation duration, and outcome. Indications were categorized as increased work of breathing, severe hypoxemia (Pao 2 < 60 mm Hg or peripheral oxygen saturation of hemoglobin as measured by pulse oximetry < 90% despite supplemental oxygen), or hypoventilation (Pa co 2 ≥ 60 mm Hg). Ventilation duration was classified as < 24 hours or ≥ 24 hours, and reasons for euthanasia were recorded when available. Results: Of 258 dogs, 85 (32.9%) survived to discharge, 105 (40.7%) were euthanized, and 68 (26.4%) died. Survival was 52.3% for dogs ventilated ≥ 24 hours compared to 13.3% for those ventilated < 24 hours. Overall, 64.7% of euthanasias occurred within 24 hours and 28.6% were financially driven. Median ventilation duration among survivors was 48 hours (range, 24 to 356 hours). Conclusions: This multi-institutional study demonstrates improved survival outcome with a 52% survival to discharge for patients ventilated ≥ 24 hours compared to patients ventilated < 24 hours. These findings suggest that once a patient surpasses the initial 24-hour period on MV, prognosis stabilizes at approximately 50:50, aligning more closely with human ICU survival rates. Clinical Relevance: These findings support MV as a viable therapeutic option in veterinary critical care, and updated survival statistics provide a basis for prognostic discussions and treatment decisions.
- 16 September 2025
- Published by Elsevier in Veterinary Clinics of North America: Small Animal Practice
- Vol. 56 (1) , 269-278
Fluid Therapy in the Hypoalbuminemic Patient
- 16 September 2025
- Published by Elsevier in Veterinary Clinics of North America: Small Animal Practice
- Vol. 56 (1) , 269-278
Fluid Therapy in the Hypoalbuminemic Patient
- Open Access
- 29 August 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (9) , 832
Norepinephrine Versus Dopamine as a First-Line Vasopressor in Dogs with Hypotension: A Pilot Study
Norepinephrine (NE) and dopamine (DA) are vasopressors used to treat vasodilatory shock for decades, and norepinephrine is considered the preferred first-line vasopressor in human patients. However, there is a dearth of evidence to support specific treatment recommendations for the management of hypotensive, non-anesthetized, fluid-replete dogs. The objective of this study was to compare the effects of NE and DA on systolic blood pressure (SBP), heart rate, and shock index (SI) when used as first-line vasopressors for the treatment of vasodilatory shock in dogs. Twenty-four client-owned canine patients of similar age, sex, and weight with hypotension necessitating vasopressor therapy were randomized to receive NE or DA; attending clinicians were blinded. Twenty-two dogs were included in the final analysis (10 in the NE group and 12 in the DA group). Seventy-seven percent of all dogs achieved normotension. In both groups, SBP increased significantly compared to baseline (p = 0.0004 in the NE group and p = 0.006 in the DA group). The SI also decreased in both groups compared to baseline values (p = 0.01 in the NE group and p = 0.01 in the DA group). The heart rate in the NE group was higher than in the DA group at timepoints 6–10 (p = 0.023). Both NE and DA cause an increase in blood pressure and a decrease in SI in dogs with vasodilatory hypotension. Further investigation is warranted to determine if there are differences between NE and DA or the requirement for a second vasopressor, occurrence of arrhythmias, length of stay, and survival.
- 29 August 2025
- Published by MDPI AG in Veterinary Sciences
- Vol. 12 (9) , 832
Open AccessNorepinephrine Versus Dopamine as a First-Line Vasopressor in Dogs with Hypotension: A Pilot Study
Norepinephrine (NE) and dopamine (DA) are vasopressors used to treat vasodilatory shock for decades, and norepinephrine is considered the preferred first-line vasopressor in human patients. However, there is a dearth of evidence to support specific treatment recommendations for the management of hypotensive, non-anesthetized, fluid-replete dogs. The objective of this study was to compare the effects of NE and DA on systolic blood pressure (SBP), heart rate, and shock index (SI) when used as first-line vasopressors for the treatment of vasodilatory shock in dogs. Twenty-four client-owned canine patients of similar age, sex, and weight with hypotension necessitating vasopressor therapy were randomized to receive NE or DA; attending clinicians were blinded. Twenty-two dogs were included in the final analysis (10 in the NE group and 12 in the DA group). Seventy-seven percent of all dogs achieved normotension. In both groups, SBP increased significantly compared to baseline (p = 0.0004 in the NE group and p = 0.006 in the DA group). The SI also decreased in both groups compared to baseline values (p = 0.01 in the NE group and p = 0.01 in the DA group). The heart rate in the NE group was higher than in the DA group at timepoints 6–10 (p = 0.023). Both NE and DA cause an increase in blood pressure and a decrease in SI in dogs with vasodilatory hypotension. Further investigation is warranted to determine if there are differences between NE and DA or the requirement for a second vasopressor, occurrence of arrhythmias, length of stay, and survival.
- 1 August 2025
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 263 (8) , 979-984
Safe use of intraoperative intraperitoneal crystalloid fluid administration in management of late-term pregnant queens undergoing elective ovariohysterectomy
Objective: Evaluate the safety and effectiveness of intraoperative IP crystalloid fluid administration for the prevention of hypotension and perfusion deficits, as well as the impact of intra-abdominal pressure (IAP), following removal of the gravid uterus in late-term pregnant queens undergoing elective ovariohysterectomy. Methods: This was a prospective, randomized, case-control study. Pregnant queens presenting to a high-volume spay-and-neuter clinic for elective ovariohysterectomy between March 2021 and May 2023 were included and randomly assigned into intraoperative IP versus postoperative SC fluid control groups. The volume of IP fluids administered was equivalent to 25% of the gravid uterus weight, while the volume of SC fluid was 22 mL/kg. Perfusion parameters and IAP measurements were collected preoperatively, during abdominal closure, and 10 minutes after surgery. Results: No difference was detected between pre- and postoperative perfusion parameters in the 50 pregnant queens (blood pressure, lactate, and IAP) between the IP and control groups. However, increased uterus weight was associated with a higher blood pressure and IAP preoperatively. No adverse effects found within the IP fluids group. Conclusions: No adverse effects or significant differences were found between IP fluid administration and control groups in 50 late-term pregnant queens. However, IP fluid administration may still be a viable option for fluid administration in shelter settings. Further veterinary studies are warranted. Clinical Relevance: Traditional fluid administration via the IV route is not always feasible in high-volume shelter settings. Studies evaluating the use of the IP fluid route and effects on perfusion parameters are important to determine its effectiveness in veterinary patients.
- 1 August 2025
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 263 (8) , 979-984
Safe use of intraoperative intraperitoneal crystalloid fluid administration in management of late-term pregnant queens undergoing elective ovariohysterectomy
Objective: Evaluate the safety and effectiveness of intraoperative IP crystalloid fluid administration for the prevention of hypotension and perfusion deficits, as well as the impact of intra-abdominal pressure (IAP), following removal of the gravid uterus in late-term pregnant queens undergoing elective ovariohysterectomy. Methods: This was a prospective, randomized, case-control study. Pregnant queens presenting to a high-volume spay-and-neuter clinic for elective ovariohysterectomy between March 2021 and May 2023 were included and randomly assigned into intraoperative IP versus postoperative SC fluid control groups. The volume of IP fluids administered was equivalent to 25% of the gravid uterus weight, while the volume of SC fluid was 22 mL/kg. Perfusion parameters and IAP measurements were collected preoperatively, during abdominal closure, and 10 minutes after surgery. Results: No difference was detected between pre- and postoperative perfusion parameters in the 50 pregnant queens (blood pressure, lactate, and IAP) between the IP and control groups. However, increased uterus weight was associated with a higher blood pressure and IAP preoperatively. No adverse effects found within the IP fluids group. Conclusions: No adverse effects or significant differences were found between IP fluid administration and control groups in 50 late-term pregnant queens. However, IP fluid administration may still be a viable option for fluid administration in shelter settings. Further veterinary studies are warranted. Clinical Relevance: Traditional fluid administration via the IV route is not always feasible in high-volume shelter settings. Studies evaluating the use of the IP fluid route and effects on perfusion parameters are important to determine its effectiveness in veterinary patients.
- 1 November 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (11) , 1-8
Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls
OBJECTIVE: To retrospectively evaluate neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a biomarker for severity and short-term outcomes of congestive heart failure (CHF) secondary to myxomatous mitral valve disease (MMVD) in dogs. ANIMALS: 47 dogs with CHF secondary to MMVD, 47 dogs with presumptive preclinical MMVD, and 47 control dogs. METHODS: Medical record data (signalment, physical examination findings, medical treatments instituted, American College of Veterinary Internal Medicine MMVD stage, length of hospitalization, outcome, and hospital re-presentation due to CHF) from March 2012 through March 2022 for each dog were collected. Statistical analyses were performed with Mann-Whitney, Spearman correlation, and Fisher exact tests. RESULTS: NLR (but not PLR) was significantly higher in dogs with CHF secondary to MMVD (6.41) compared to presumptive preclinical MMVD dogs (4.66; P < .001) and control dogs (3.95; P < .001). Dogs with higher NLR and PLR received significantly higher cumulative dosages of loop-diuretic therapy during hospitalization (ρ = 0.3, P = .04; and ρ = 0.4, P = .02, respectively). There was a positive association between NLR and duration of oxygen supplementation within the CHF group (ρ = 0.4; P = .01). CLINICAL RELEVANCE: The increased diuretic dose and time receiving oxygen supplementation may represent increased disease severity for which NLR (and to a lesser extent PLR) may serve as a readily available marker. The data presented provide information regarding some of the systemic inflammatory changes seen in CHF secondary to MMVD in dogs. Future research should include prospective, longitudinal studies to provide insight into the long-term prognostic value of NLR and PLR in dogs with CHF.
- 1 November 2023
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 261 (11) , 1-8
Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls
OBJECTIVE: To retrospectively evaluate neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as a biomarker for severity and short-term outcomes of congestive heart failure (CHF) secondary to myxomatous mitral valve disease (MMVD) in dogs. ANIMALS: 47 dogs with CHF secondary to MMVD, 47 dogs with presumptive preclinical MMVD, and 47 control dogs. METHODS: Medical record data (signalment, physical examination findings, medical treatments instituted, American College of Veterinary Internal Medicine MMVD stage, length of hospitalization, outcome, and hospital re-presentation due to CHF) from March 2012 through March 2022 for each dog were collected. Statistical analyses were performed with Mann-Whitney, Spearman correlation, and Fisher exact tests. RESULTS: NLR (but not PLR) was significantly higher in dogs with CHF secondary to MMVD (6.41) compared to presumptive preclinical MMVD dogs (4.66; P < .001) and control dogs (3.95; P < .001). Dogs with higher NLR and PLR received significantly higher cumulative dosages of loop-diuretic therapy during hospitalization (ρ = 0.3, P = .04; and ρ = 0.4, P = .02, respectively). There was a positive association between NLR and duration of oxygen supplementation within the CHF group (ρ = 0.4; P = .01). CLINICAL RELEVANCE: The increased diuretic dose and time receiving oxygen supplementation may represent increased disease severity for which NLR (and to a lesser extent PLR) may serve as a readily available marker. The data presented provide information regarding some of the systemic inflammatory changes seen in CHF secondary to MMVD in dogs. Future research should include prospective, longitudinal studies to provide insight into the long-term prognostic value of NLR and PLR in dogs with CHF.
- Open Access
Comparison of Mean Arterial Blood Pressure and Heart Rate Changes in Response to Three Different Randomized Isotonic Crystalloid Boluses in Hypotensive Anesthetized Dogs
The aim of this prospective, randomized, nonblinded, controlled clinical trial was to compare mean arterial blood pressure (MAP) and heart rate (HR) during an intravenous bolus of three different balanced isotonic crystalloid solutions in euvolemic, anesthetized dogs with hypotension. Thirty healthy dogs (American Society of Anesthesiologists Physical Status I–II) weighing at least 15 kg that presented for elective orthopedic or dental surgical procedures at the Ryan Veterinary Hospital for Small Animals of the University of Pennsylvania were included in this study. Anesthetized hypotensive patients (defined as a MAP ≤ 65 mmHg), were administered an infusion of Lactated Ringer’s solution (LRS), Plasma-Lyte (PLYTE) or Canadian Plasma-Lyte (PLYTECA), selected at random. The infusion was administered over 15 min via a volumetric fluid pump. Differences in oscillometric MAP and HR between time points and across treatments were evaluated by mANOVA. Intravenous isotonic crystalloid infusions over 15 min did not significantly change MAP or HR in hypotensive dogs under general anesthesia. Neither LRS, PLYTE nor PLYTECA exacerbated hypotension or caused tachycardia.
Open AccessComparison of Mean Arterial Blood Pressure and Heart Rate Changes in Response to Three Different Randomized Isotonic Crystalloid Boluses in Hypotensive Anesthetized Dogs
The aim of this prospective, randomized, nonblinded, controlled clinical trial was to compare mean arterial blood pressure (MAP) and heart rate (HR) during an intravenous bolus of three different balanced isotonic crystalloid solutions in euvolemic, anesthetized dogs with hypotension. Thirty healthy dogs (American Society of Anesthesiologists Physical Status I–II) weighing at least 15 kg that presented for elective orthopedic or dental surgical procedures at the Ryan Veterinary Hospital for Small Animals of the University of Pennsylvania were included in this study. Anesthetized hypotensive patients (defined as a MAP ≤ 65 mmHg), were administered an infusion of Lactated Ringer’s solution (LRS), Plasma-Lyte (PLYTE) or Canadian Plasma-Lyte (PLYTECA), selected at random. The infusion was administered over 15 min via a volumetric fluid pump. Differences in oscillometric MAP and HR between time points and across treatments were evaluated by mANOVA. Intravenous isotonic crystalloid infusions over 15 min did not significantly change MAP or HR in hypotensive dogs under general anesthesia. Neither LRS, PLYTE nor PLYTECA exacerbated hypotension or caused tachycardia.
- 21 June 2022
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 51 (4) , 533-542
Clinical application of the StatSensor and StatSensor Xpress point‐of‐care creatinine measurement devices in dogs
Background Creatinine is a universally important blood parameter used to detect and monitor acute and chronic kidney disease. Reliable measurements at the bedside remain a challenge in human and veterinary medicine. Despite its potential, a trustworthy point-of-care creatinine biosensor has yet to be established. Objectives We aimed to determine the precision and accuracy of the StatSensor (SS) and StatSensor Xpress (SSX) handheld creatinine measurement devices in dogs. Methods Paired creatinine samples from dogs with normal (creatinine <= 159 mu mol/L), moderate (159-354 mu mol/L), and marked (>354 mu mol/L) azotemia were compared with a commercial enzymatic analyzer. Within-day precision and linearity studies were performed prior to method comparison studies. Method comparison was evaluated using Bland-Altman, concordance correlation coefficient, Deming, and Passing-Bablok regression analysis. Results Seventy-eight dogs were enrolled in the study, including 28 (35%), 25 (32%), and 26 (33%) with normal, moderate, and marked azotemia. Total error surpassed recommendations for all devices, and linearity deviated from identity for the SS1 and SS2. The concordance correlation coefficients of the SS1, SS2, SSXI, and SSX2, were 0.69, 0.59, 0.82, and 0.44, respectively. Bland-Altman analyses showed a high variation in the differences, and relationships showed high heteroskedasticity with negative systemic bias among high creatinine concentrations. Conclusions Neither the SS and SSX are considered acceptable for clinical applications in dogs. Further research is indicated for the development of a reliable, cost-effective, point-of-care creatinine analyzer to improve the rapid detection and monitoring human and veterinary patients.
- 21 June 2022
- Published by Wiley in Veterinary Clinical Pathology
- Vol. 51 (4) , 533-542
Clinical application of the StatSensor and StatSensor Xpress point‐of‐care creatinine measurement devices in dogs
Background Creatinine is a universally important blood parameter used to detect and monitor acute and chronic kidney disease. Reliable measurements at the bedside remain a challenge in human and veterinary medicine. Despite its potential, a trustworthy point-of-care creatinine biosensor has yet to be established. Objectives We aimed to determine the precision and accuracy of the StatSensor (SS) and StatSensor Xpress (SSX) handheld creatinine measurement devices in dogs. Methods Paired creatinine samples from dogs with normal (creatinine <= 159 mu mol/L), moderate (159-354 mu mol/L), and marked (>354 mu mol/L) azotemia were compared with a commercial enzymatic analyzer. Within-day precision and linearity studies were performed prior to method comparison studies. Method comparison was evaluated using Bland-Altman, concordance correlation coefficient, Deming, and Passing-Bablok regression analysis. Results Seventy-eight dogs were enrolled in the study, including 28 (35%), 25 (32%), and 26 (33%) with normal, moderate, and marked azotemia. Total error surpassed recommendations for all devices, and linearity deviated from identity for the SS1 and SS2. The concordance correlation coefficients of the SS1, SS2, SSXI, and SSX2, were 0.69, 0.59, 0.82, and 0.44, respectively. Bland-Altman analyses showed a high variation in the differences, and relationships showed high heteroskedasticity with negative systemic bias among high creatinine concentrations. Conclusions Neither the SS and SSX are considered acceptable for clinical applications in dogs. Further research is indicated for the development of a reliable, cost-effective, point-of-care creatinine analyzer to improve the rapid detection and monitoring human and veterinary patients.
- Open Access
- 15 January 2022
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 260 (S1) , S40-S45
Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate
OBJECTIVE: To compare effectiveness of maropitant and ondansetron in preventing preoperative vomiting and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate. ANIMALS: 88 dogs owned by rescue organizations. PROCEDURES: Dogs received maropitant (n = 29) or ondansetron (28) PO 2 hours prior to premedication or did not receive an antiemetic (31; control). Dogs were evaluated for vomiting, nausea, and severity of nausea (scored for 6 signs) for 15 minutes following premedication with hydromorphone, acepromazine, and glycopyrrolate. RESULTS: A significantly lower percentage of dogs vomited after receiving maropitant (3/29 [10%]), compared with control dogs (19/31 [62%]) and dogs that received ondansetron (15/28 [54%]). A significantly lower percentage of dogs appeared nauseated after receiving maropitant (3/29 [10%]), compared with control dogs (27/31 [87%]) and dogs that received ondansetron (14/28 [50%]), and a significantly lower percentage of dogs appeared nauseated after receiving ondansetron, compared with control dogs. Nausea severity scores for hypersalivation, lip licking, hard swallowing, and hunched posture were significantly lower for dogs that received maropitant than for control dogs, and scores for hypersalivation, lip licking, and hard swallowing were significantly lower for dogs that received ondansetron than for control dogs. CONCLUSIONS AND CLINICAL RELEVANCE: Oral administration of maropitant 2 hours prior to premedication with hydromorphone reduced the incidence of vomiting and the incidence and severity of nausea in healthy dogs. Oral administration of ondansetron reduced the incidence and severity of nausea but not the incidence of vomiting.
- 15 January 2022
- Published by American Veterinary Medical Association (AVMA) in Journal of the American Veterinary Medical Association
- Vol. 260 (S1) , S40-S45
Open AccessEffectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate
OBJECTIVE: To compare effectiveness of maropitant and ondansetron in preventing preoperative vomiting and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate. ANIMALS: 88 dogs owned by rescue organizations. PROCEDURES: Dogs received maropitant (n = 29) or ondansetron (28) PO 2 hours prior to premedication or did not receive an antiemetic (31; control). Dogs were evaluated for vomiting, nausea, and severity of nausea (scored for 6 signs) for 15 minutes following premedication with hydromorphone, acepromazine, and glycopyrrolate. RESULTS: A significantly lower percentage of dogs vomited after receiving maropitant (3/29 [10%]), compared with control dogs (19/31 [62%]) and dogs that received ondansetron (15/28 [54%]). A significantly lower percentage of dogs appeared nauseated after receiving maropitant (3/29 [10%]), compared with control dogs (27/31 [87%]) and dogs that received ondansetron (14/28 [50%]), and a significantly lower percentage of dogs appeared nauseated after receiving ondansetron, compared with control dogs. Nausea severity scores for hypersalivation, lip licking, hard swallowing, and hunched posture were significantly lower for dogs that received maropitant than for control dogs, and scores for hypersalivation, lip licking, and hard swallowing were significantly lower for dogs that received ondansetron than for control dogs. CONCLUSIONS AND CLINICAL RELEVANCE: Oral administration of maropitant 2 hours prior to premedication with hydromorphone reduced the incidence of vomiting and the incidence and severity of nausea in healthy dogs. Oral administration of ondansetron reduced the incidence and severity of nausea but not the incidence of vomiting.
- 28 June 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (5) , 585-594
Standardized capillary refill time and relation to clinical parameters in hospitalized dogs
Objective To assess the relationship between various physical and clinicopathologic parameters and the capillary refill time (CRT) using a standard method; to evaluate the influence of emergency room (ER) versus ICU hospital location on CRT; and to identify latent subgroups among the CRT distribution. Design Prospective, observational study. Setting University teaching hospital. Animals Client-owned dogs in the ER (n = 40) and ICU (n = 71). Interventions The CRT was defined as the duration required for the oral mucosa of the upper lip to return to its original color after blanching for 4 seconds. The CRT was recorded in seconds to the 10ths place by a single observer using an automated recording device. Measurements and Main Results Median CRT for all dogs was 1.1 seconds (ER, 1.2 s; ICU, 1.1 s; P = 1.000). The CRT was significantly associated with rectal temperature (P = 0.004), systolic blood pressure (P = 0.028), body weight (P = 0.031), mucous membrane color (P = 0.007), skin turgor (P = 0.039), and acute patient physiologic and laboratory evaluation mentation score (P = 0.019) for all dogs. The CRT was related to a greater number of variables in the ER than in the ICU patient population. In general, the total population of dogs had CRTs belonging to 1 of 2 groups: either ≤1.2 or ≥1.7 seconds. A statistically significant association was found between body weight CRT ≥1.3 seconds (P = 0.02). Conclusions A CRT following blanching for 4 seconds may provide insight into the hydration status and hemodynamic stability of canine patients. Further research into its clinical application is warranted.
- 28 June 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (5) , 585-594
Standardized capillary refill time and relation to clinical parameters in hospitalized dogs
Objective To assess the relationship between various physical and clinicopathologic parameters and the capillary refill time (CRT) using a standard method; to evaluate the influence of emergency room (ER) versus ICU hospital location on CRT; and to identify latent subgroups among the CRT distribution. Design Prospective, observational study. Setting University teaching hospital. Animals Client-owned dogs in the ER (n = 40) and ICU (n = 71). Interventions The CRT was defined as the duration required for the oral mucosa of the upper lip to return to its original color after blanching for 4 seconds. The CRT was recorded in seconds to the 10ths place by a single observer using an automated recording device. Measurements and Main Results Median CRT for all dogs was 1.1 seconds (ER, 1.2 s; ICU, 1.1 s; P = 1.000). The CRT was significantly associated with rectal temperature (P = 0.004), systolic blood pressure (P = 0.028), body weight (P = 0.031), mucous membrane color (P = 0.007), skin turgor (P = 0.039), and acute patient physiologic and laboratory evaluation mentation score (P = 0.019) for all dogs. The CRT was related to a greater number of variables in the ER than in the ICU patient population. In general, the total population of dogs had CRTs belonging to 1 of 2 groups: either ≤1.2 or ≥1.7 seconds. A statistically significant association was found between body weight CRT ≥1.3 seconds (P = 0.02). Conclusions A CRT following blanching for 4 seconds may provide insight into the hydration status and hemodynamic stability of canine patients. Further research into its clinical application is warranted.
- 20 May 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (4) , 508-515
Effectiveness of intravenous fluid resuscitation in hypotensive cats: 82 cases (2012–2019)
Objective To evaluate the effectiveness of intravenous fluid resuscitation in hypotensive cats in an emergency room setting. Secondary objectives were to investigate changes in heart rate (HR) and body temperature (BT) in response to fluid resuscitation, and the association of these changes with patient survival. Design Retrospective study. Setting University teaching hospital. Animals Eighty-two cats with confirmed hypotension. Interventions None. Measurements and main results Medical records from 2012 to 2019 were searched for cats that had documented systemic arterial hypotension (blood pressure measured using a Doppler ultrasonic flow probe [DBP] < 90 mm Hg) on presentation to the emergency room. Data collected included patient characteristics and DBP, HR, and BT before and after fluid resuscitation, type and volume of fluids administered, and outcome. The median DBP before and after resuscitative fluid therapy in all cats was 65 mm Hg (range, 20–85 mm Hg) and 80 mm Hg (range, 20–128 mm Hg), respectively (P < 0.001). However, only 30 cats (37%) were classified as responders to fluid resuscitation (DBP ≥ 90 mm Hg following bolus therapy). The mean HR and median BT before resuscitative fluid therapy was 159/min and 36.7°C. Following fluid resuscitation, where measured, the mean HR and median BT was 154/min (P = 1.00) and 35.9°C (P = 1.00). No significant differences in HR and BT were identified between responders and non-responders. Cats had a low survival rate of 7%. All survivors (n = 5) were initially bradycardic (HR < 160/min), compared to only 45% of non-survivors (P = 0.4). Conclusions Bolus fluid resuscitation effectively increases blood pressure in hypotensive cats; however, it does not result in normalization of blood pressure, HR, or BT in the majority of cases.
- 20 May 2021
- Published by Wiley in Journal of Veterinary Emergency and Critical Care
- Vol. 31 (4) , 508-515
Effectiveness of intravenous fluid resuscitation in hypotensive cats: 82 cases (2012–2019)
Objective To evaluate the effectiveness of intravenous fluid resuscitation in hypotensive cats in an emergency room setting. Secondary objectives were to investigate changes in heart rate (HR) and body temperature (BT) in response to fluid resuscitation, and the association of these changes with patient survival. Design Retrospective study. Setting University teaching hospital. Animals Eighty-two cats with confirmed hypotension. Interventions None. Measurements and main results Medical records from 2012 to 2019 were searched for cats that had documented systemic arterial hypotension (blood pressure measured using a Doppler ultrasonic flow probe [DBP] < 90 mm Hg) on presentation to the emergency room. Data collected included patient characteristics and DBP, HR, and BT before and after fluid resuscitation, type and volume of fluids administered, and outcome. The median DBP before and after resuscitative fluid therapy in all cats was 65 mm Hg (range, 20–85 mm Hg) and 80 mm Hg (range, 20–128 mm Hg), respectively (P < 0.001). However, only 30 cats (37%) were classified as responders to fluid resuscitation (DBP ≥ 90 mm Hg following bolus therapy). The mean HR and median BT before resuscitative fluid therapy was 159/min and 36.7°C. Following fluid resuscitation, where measured, the mean HR and median BT was 154/min (P = 1.00) and 35.9°C (P = 1.00). No significant differences in HR and BT were identified between responders and non-responders. Cats had a low survival rate of 7%. All survivors (n = 5) were initially bradycardic (HR < 160/min), compared to only 45% of non-survivors (P = 0.4). Conclusions Bolus fluid resuscitation effectively increases blood pressure in hypotensive cats; however, it does not result in normalization of blood pressure, HR, or BT in the majority of cases.